Compare STT & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STT | BDX |
|---|---|---|
| Founded | 1792 | 1897 |
| Country | United States | United States |
| Employees | 51425 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 51.5B |
| IPO Year | N/A | 1996 |
| Metric | STT | BDX |
|---|---|---|
| Price | $155.22 | $147.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $148.86 | ★ $186.00 |
| AVG Volume (30 Days) | 1.5M | ★ 2.9M |
| Earning Date | 04-17-2026 | 05-07-2026 |
| Dividend Yield | 2.23% | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $7.66 | N/A |
| Revenue Next Year | $3.87 | $3.02 |
| P/E Ratio | ★ $13.80 | $590.36 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $94.72 | $141.82 |
| 52 Week High | $159.31 | $213.08 |
| Indicator | STT | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.18 | 46.38 |
| Support Level | $147.61 | $141.82 |
| Resistance Level | $156.18 | $158.66 |
| Average True Range (ATR) | 2.92 | 4.07 |
| MACD | -0.14 | 0.73 |
| Stochastic Oscillator | 66.22 | 56.95 |
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $54 trillion in assets under custody and administration, and $5.7 trillion in assets under management, as of Dec. 31, 2025, State Street operates globally in more than 100 geographic markets and employs about 51,500 worldwide.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.